Medartis Holding AG held an investor and media event in Basel on June 4 around the FESSH hand surgery congress. CEO Matthias Schupp welcomed attendees and outlined the company's strategy roadmap.
The event took place amid rainy weather in Basel, Switzerland. Schupp noted the company's recent progress as of the end of May and highlighted upcoming presentations on innovation. Marc Ammann, executive vice president of research and development, was scheduled to discuss the product roadmap including a new U.S. launch referred to as the Sexy Nail. Dr. Daniel Herren of the Schulthess Clinic in Zurich was also invited to speak on CMC1 prosthesis. Schupp described Medartis as becoming disruptive in its approach to upper extremities and hand products during the world's largest hand congress.